Filing Details

Accession Number:
0001209191-20-038334
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-06-22 20:58:11
Reporting Period:
2020-06-18
Accepted Time:
2020-06-22 20:58:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1006028 Pure Bioscience Inc. PURE Miscellaneous Chemical Products (2890) 330530289
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1623609 Y Tom Lee 1807 San Gabriel Blvd.
San Gabriel CA 91776
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-06-18 30,000 $1.75 4,594,523 No 4 P Direct
Common Stock Acquisiton 2020-06-19 10,000 $1.85 4,604,523 No 4 P Direct
Common Stock Acquisiton 2020-06-22 13,124 $1.72 4,617,647 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 24,134,173 Indirect By Plum Investments, L.P.
Common Stock 1,000,000 Indirect By Kamika Shay Lee Trust Dated July 1, 2019
Common Stock 1,000,000 Indirect By Karissa Shay Lee Trust Dated July 1, 2019
Common Stock 1,000,000 Indirect By Tessa Melody Shin Trust Dated February 12, 2020
Common Stock 717,665 Indirect By wife
Footnotes
  1. This transaction was executed in multiple purchases through a purchase order executed by a broker-dealer at prices ranging from $1.62 to $1.83. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  2. This transaction was executed in multiple purchases through a purchase order executed by a broker-dealer at prices ranging from $1.61 to $1.82. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  3. Mr. Lee is the general partner of Plum Investments, L.P., and has ultimate voting and investment control over the shares held by Plum Investments, L.P.
  4. Mr. Lee is a trustee of the Kamika Shay Lee Trust Dated July 1, 2019, Karissa Shay Lee Trust Dated July 1, 2019 and Tessa Melody Shin Trust Dated February 12, 2020 and has voting and dispositive power with respect to these shares